Aroa Biosurgery names Michael Lynskey and Mike Falcon to U.S. commercial team

The appointments are aimed at supporting AROA ECM technology growth, expanding the Myriad portfolio and capturing a larger outpatient wound-care opportunity for Symphony after a market reset.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.